Pneumococcal Vaccine Clinical Study
If you haven’t been vaccinated against pneumococcal disease, you may be eligible for a clinical study.
Pneumococcus can cause serious diseases.
Right now, a clinical study is testing an investigational vaccine to learn about the safety and immune responses it produces against 20 strains of pneumococcus (Streptococcus pneumoniae), a type of bacteria that can lead to pneumonia, blood infection, and other serious diseases.
If you take part in our clinical research study, you will receive either an investigational or an approved vaccine that may help prevent pneumococcal disease. You will also receive study-related medical care and reimbursement for travel.
This study is for research purposes only. There may not be a direct benefit to you if you take part, but information learned from the study may help other people in the future.